Literature DB >> 11096493

Hypertrophic Cardiomyopathy.

.   

Abstract

The degree of clinical expression of both obstructive and nonobstructive hypertrophic cardiomyopathy (HCM) is widely variable. Many patients with HCM are asymptomatic or minimally symptomatic. Most patients with mild or moderate HCM respond well to medical therapy, but medical therapy in patients with severe disease is only marginally beneficial. In some instances, medical therapy can even complicate management by producing significant conduction disturbances. Most symptomatic patients with a significant resting outflow tract gradient may respond to atrioventricular sequential electronic pacing. Most of these patients eventually become symptomatic again, however, because of progression of the disease process or other unknown factors. The outcome of myotomy-myectomy depends greatly on the surgeon's experience with this surgical procedure. In patients with very severe hypertrophy or evidence of left ventricular dilatation and systolic dysfunction, cardiac transplantation should be considered earlier than it would be on the basis of symptoms, functional capacity, and other factors.

Entities:  

Year:  1999        PMID: 11096493     DOI: 10.1007/s11936-999-0044-2

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  18 in total

Review 1.  Hypertrophic cardiomyopathy.

Authors:  B J Maron
Journal:  Lancet       Date:  1997-07-12       Impact factor: 79.321

2.  Hypertrophic cardiomyopathy--continued progress.

Authors:  E Braunwald
Journal:  N Engl J Med       Date:  1989-03-23       Impact factor: 91.245

Review 3.  Hypertrophic cardiomyopathy.

Authors:  E K Louie; L C Edwards
Journal:  Prog Cardiovasc Dis       Date:  1994 Jan-Feb       Impact factor: 8.194

4.  Effects of disopyramide on left ventricular diastolic function in hypertrophic cardiomyopathy.

Authors:  M A Fifer; P T O'Gara; B A McGovern; M J Semigran
Journal:  Am J Cardiol       Date:  1994-08-15       Impact factor: 2.778

5.  Arrhythmia as a cause of sudden death in hypertrophic cardiomyopathy.

Authors:  J F Goodwin; D M Krikler
Journal:  Lancet       Date:  1976-10-30       Impact factor: 79.321

6.  Disopyramide as a negative inotrope in obstructive cardiomyopathy in children.

Authors:  W J Duncan; M J Tyrrell; B B Bharadwaj
Journal:  Can J Cardiol       Date:  1991-03       Impact factor: 5.223

7.  Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy.

Authors:  U Sigwart
Journal:  Lancet       Date:  1995-07-22       Impact factor: 79.321

8.  Subaortic stenosis revisited: the importance of the dynamic pressure gradient.

Authors:  J M Criley; R J Siegel
Journal:  Medicine (Baltimore)       Date:  1993-11       Impact factor: 1.889

9.  Long-term clinical and echocardiographic follow-up after surgical correction of hypertrophic obstructive cardiomyopathy with extended myectomy and reconstruction of the subvalvular mitral apparatus.

Authors:  F A Schoendube; H G Klues; S Reith; F A Flachskampf; P Hanrath; B J Messmer
Journal:  Circulation       Date:  1995-11-01       Impact factor: 29.690

10.  Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy.

Authors:  R C Robbins; E B Stinson
Journal:  J Thorac Cardiovasc Surg       Date:  1996-03       Impact factor: 5.209

View more
  2 in total

1.  Enhanced active cross-bridges during diastole: molecular pathogenesis of tropomyosin's HCM mutations.

Authors:  Fan Bai; Adam Weis; Aya K Takeda; P Bryant Chase; Masataka Kawai
Journal:  Biophys J       Date:  2011-02-16       Impact factor: 4.033

Review 2.  A study of tropomyosin's role in cardiac function and disease using thin-filament reconstituted myocardium.

Authors:  Fan Bai; Li Wang; Masataka Kawai
Journal:  J Muscle Res Cell Motil       Date:  2013-05-23       Impact factor: 2.698

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.